RSV F protein — Drug Target
All drugs that target RSV F protein — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (2)
- RSVpreF MDV · Pfizer Inc. · Monoclonal antibody · Infectious Disease
- RSVpreF · Pfizer · Monoclonal antibody · Infectious Disease
Phase 3 pipeline (1)
- motavizumab (MEDI-524) · MedImmune LLC · Monoclonal antibody · Respiratory
Motavizumab is a monoclonal antibody that targets the respiratory syncytial virus (RSV) F-protein.